Biocon Limited
Biocon Limited, together with its subsidiaries, manufactures and sells biotechnology products and research services in India, the United States, Ireland, rest of the European Union, and internationally. It operates through Generics, Biosimilars, and Research segments. The company offers generic formulations and API products, including cardiovascular, anti-diabetics, obesity, multiple sclerosis, a… Read more
Market Cap & Net Worth: Biocon Limited (BIOCON)
Biocon Limited (NSE:BIOCON) has a market capitalization of $7.15 Billion (₹619.56 Billion) as of March 19, 2026. Listed on the NSE stock exchange, this India-based company holds position #4299 globally and #143 in its home market, demonstrating a -1.82% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Biocon Limited's stock price ₹382.60 by its total outstanding shares 1619331350 (1.62 Billion).
Biocon Limited Market Cap History: 2015 to 2026
Biocon Limited's market capitalization history from 2015 to 2026. Data shows growth from $1.57 Billion to $7.15 Billion (17.02% CAGR).
Index Memberships
Biocon Limited is a constituent of 11 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY PHARMA
CNXPHARMA
|
$57.77 Billion | 4.46% | #10 of 20 |
|
NIFTY MIDCAP 100
NIFMDCP100
|
$276.24 Billion | 0.93% | #46 of 100 |
|
NIFTY100 EQUAL WEIGHT
NIFTY100EW
|
$686.34 Billion | 0.38% | #65 of 99 |
|
NIFTY 200
NIFTY200
|
$1.03 Trillion | 0.25% | #118 of 200 |
|
NIFTY 500
NIFTY500
|
$1.29 Trillion | 0.20% | #132 of 500 |
|
NIFTY ALHPA 50
NIFTYALI
|
$170.53 Billion | 1.51% | #21 of 47 |
|
NIFTY HEALTHCARE
NIFTYHEALTHCARE
|
$72.07 Billion | 3.57% | #12 of 20 |
|
Nifty Low Volatility 50
NIFTYLVI
|
$402.81 Billion | 0.64% | #32 of 48 |
|
NIFTY MIDCAP 150
NIFTYMIDCAP150
|
$344.35 Billion | 0.75% | #52 of 150 |
|
NIFTY MIDSMALLCAP 400
NIFTYMIDSML400
|
$539.70 Billion | 0.48% | #64 of 400 |
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$1.35 Trillion | 0.19% | #133 of 750 |
Weight: Biocon Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Biocon Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Biocon Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.05x
Biocon Limited's market cap is 0.05 times its annual revenue
1740.90x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.73x
Biocon Limited's market cap is 0.73 times its annual earnings
0.11x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $2.92 Billion | $33.47 Billion | $8.96 Billion | 0.09x | 0.33x |
| 2017 | $4.96 Billion | $38.91 Billion | $6.12 Billion | 0.13x | 0.81x |
| 2018 | $5.82 Billion | $41.23 Billion | $3.72 Billion | 0.14x | 1.56x |
| 2019 | $5.44 Billion | $55.14 Billion | $9.05 Billion | 0.10x | 0.60x |
| 2020 | $8.63 Billion | $63.01 Billion | $7.48 Billion | 0.14x | 1.15x |
| 2021 | $6.76 Billion | $71.43 Billion | $7.41 Billion | 0.09x | 0.91x |
| 2022 | $4.86 Billion | $81.84 Billion | $6.48 Billion | 0.06x | 0.75x |
| 2023 | $4.66 Billion | $111.74 Billion | $4.63 Billion | 0.04x | 1.01x |
| 2024 | $6.83 Billion | $147.56 Billion | $10.22 Billion | 0.05x | 0.67x |
| 2025 | $7.37 Billion | $152.62 Billion | $10.13 Billion | 0.05x | 0.73x |
Competitor Companies of BIOCON by Market Capitalization
Companies near Biocon Limited in the global market cap rankings as of March 19, 2026.
Key companies related to Biocon Limited by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #165 globally with a market cap of $114.33 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #285 globally with a market cap of $73.32 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #340 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #497 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $114.33 Billion | $451.59 |
| #285 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $73.32 Billion | $744.12 |
| #340 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #497 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Biocon Limited Historical Marketcap From 2015 to 2026
Between 2015 and today, Biocon Limited's market cap moved from $1.57 Billion to $ 7.15 Billion, with a yearly change of 17.02%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₹7.15 Billion | -2.87% |
| 2025 | ₹7.37 Billion | +7.81% |
| 2024 | ₹6.83 Billion | +46.55% |
| 2023 | ₹4.66 Billion | -4.10% |
| 2022 | ₹4.86 Billion | -28.08% |
| 2021 | ₹6.76 Billion | -21.65% |
| 2020 | ₹8.63 Billion | +58.46% |
| 2019 | ₹5.44 Billion | -6.44% |
| 2018 | ₹5.82 Billion | +17.27% |
| 2017 | ₹4.96 Billion | +70.11% |
| 2016 | ₹2.92 Billion | +85.29% |
| 2015 | ₹1.57 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Biocon Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $7.15 Billion USD |
| MoneyControl | $7.15 Billion USD |
| MarketWatch | $7.15 Billion USD |
| marketcap.company | $7.15 Billion USD |
| Reuters | $7.15 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.